TABLE 3.
PV50 and PVmax of QPX7728 for enhancement of activity of biapenem against isogenic strains of KPC-2-producing P. aeruginosa overexpressing or lacking MDR RND efflux pumps
| Straina | Genotype/description | BLI | Biapenem MIC (μg/ml) in the presence of the following concn of BLIs (μg/ml)b: |
Biapenem MIC (μg/ml) for vector-only control | GM biapenem MICc (μg/ml) | PV50d (μg/ml) | PVmaxe (μg/ml) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 0.06 | 0.13 | 0.25 | 0.5 | 1 | 2 | 4 | 8 | 16 | 32 | 64 | |||||||
| PAM4224 | Wild type | QPX7728 | 64 | 64 | 32 | 32 | 16 | 2 | 1 | 0.06 | 0.06 | 0.06 | 0.06 | 0.03 | 0.25 | 4 | 1 | 4 |
| PAM4135 | oprM::Hg | QPX7728 | 64 | 32 | 32 | 32 | 16 | 2 | 0.5 | 0.06 | 0.03 | NG | NG | NG | 0.25 | 4 | 1 | 4 |
| PAM4365 | mexA::Tet | QPX7728 | 64 | 32 | 32 | 16 | 8 | 2 | 0.5 | 0.125 | 0.125 | NG | NG | NG | 0.25 | 4 | 1 | 4 |
| PAM4126 | mexR (MexAB-OprM)f | QPX7728 | 64 | 16 | 16 | 16 | 16 | 4 | 1 | 0.25 | 0.125 | 0.125 | 0.125 | 0.125 | 0.125 | 2.8 | 2 | 8 |
| PAM4129 | nfxB (MexCD-OprJ) | QPX7728 | 8 | 8 | 4 | 4 | 0.5 | 0.06 | 0.03 | 0.03 | 0.03 | 0.03 | 0.3 | NG | 0.03 | 0.5 | 0.5 | 2 |
| PAM4132 | mexT (MexEF-OprM)g | QPX7728 | 128 | 128 | 128 | 64 | 32 | 8 | 2 | 0.5 | 0.25 | 0.25 | 0.25 | 0.125 | 0.5 | 8 | 1 | 4 |
| PAM4150 | mexZ (MexXY-OprM) | QPX7728 | 64 | 32 | 32 | 16 | 8 | 2 | 1 | 0.25 | 0.25 | 0.25 | 0.25 | 0.125 | 0.25 | 4 | 1 | 4 |
| PAM4224 | Wild type | Vaborbactam | 64 | 64 | 64 | 64 | 32 | 32 | 16 | 8 | 4 | 2 | 2 | 1 | 0.25 | 4 | 8 | >64 |
| PAM4135 | oprM::Hg | Vaborbactam | 64 | 32 | 32 | 16 | 4 | 2 | 0.5 | 0.5 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 4 | 0.5 | 8 |
| PAM4365 | mexA::Tet | Vaborbactam | 64 | 32 | 32 | 16 | 4 | 2 | 1 | 0.5 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 4 | 0.5 | 4 |
| PAM4126 | mexR (MexAB-OprM) | Vaborbactam | 64 | 64 | 64 | 64 | 64 | 64 | 64 | 16 | 16 | 8 | 4 | 2 | 0.125 | 2.8 | 64 | >64 |
| PAM4129 | nfxB (MexCD-OprJ) | Vaborbactam | 8 | 8 | 8 | 8 | 4 | 2 | 1 | 0.5 | 0.25 | 0.125 | 0.06 | 0.03 | 0.03 | 0.5 | 4 | 64 |
| PAM4132 | mexT (MexEF-OprM) | Vaborbactam | 128 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 64 | 0.5 | 8 | >64 | >64 |
| PAM4150 | mexZ (MexXY-OprM) | Vaborbactam | 64 | 64 | 64 | 32 | 32 | 32 | 16 | 8 | 4 | 4 | 2 | 1 | 0.25 | 4 | 8 | >64 |
All strains produced KPC-2, the gene for which was carried by recombinant plasmid pUCP24-KPC-2.
Biapenem MICs in the presence of BLIs at PV50 and PVmax are marked in italics and boldface, respectively. NG, no growth.
GM MIC, the geometric mean of the antibiotic MIC values for the beta-lactamase-producing and the vector-only control strain (calculated as the square root of the product of the antibiotic MIC values for the beta-lactamase-producing and the vector-only control strain).
PV50, the concentration of a BLI required to achieve a 50% antibiotic potentiation effect or the concentration of a BLI required to reduce the antibiotic MIC to or below the middle point of the MIC range between the MIC for the beta-lactamase-producing strain and the MIC for the vector-only control strain. The MIC middle point is the geometric mean of the antibiotic MIC values for the beta-lactamase-producing and the vector-only control strain.
PVmax, maximal potentiating value, or the concentration of the BLI that reduces the antibiotic MIC to the level seen in the parent strain that lacks KPC (corresponding to the complete inhibition of KPC).
The specific efflux pump overexpressed due to mutations in respective regulators is shown in parentheses.
A mutation in mexT also results in a partial downregulation of the carbapenem-specific porin oprD.